Answers are grounded in this paper and cite their sources.
Vasodilating agents exhibit species- and region-specific responses on vascular smooth muscle in vitro, highlighting the need to account for these variations in preclinical drug testing.
Vasodilating agents were tested on smooth-muscle strips of small arterial blood vessels of dog and rabbit skin and mesentery, and two patterns of reaction were demonstrated. The type 1 Vasodilating agents, for example nicotinate, caused relaxation of contracted strips or blocked their contraction. The type 2 Vasodilating compounds, histamine, choline esters, and bradykinin, either caused contraction or had no effect on the vascular smooth-muscle preparation. Responses that were species specific and region specific characterize the action of type 2 vasodilators and must be accounted for in any in-vitro testing procedure for vasodilator drugs.
No takes yet. Share an insight, caveat, or question.
Winkelmann et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: